Cytokinetics sues Bristol-Myers Squibb over aficamten patent dispute
Go back to Cytokinetics sues Bristol-Myers Squibb over aficamten patent dispute| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 62.62 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.62 | 52 Week High | $77.12 | |||
| Open | $62.62 | 52 Week Low | $49.03 | |||
| Day High | $62.62 | P/E | 40.66 | |||
| Day Low | $62.62 | EPS | $1.54 | |||
| Volume | 3,404 | |||||
| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 67.56 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.56 | 52 Week High | $13.18 | |||
| Open | $67.56 | 52 Week Low | $6.00 | |||
| Day High | $67.56 | P/E | N/A | |||
| Day Low | $67.56 | EPS | $-1.24 | |||
| Volume | 16 | |||||
